Project Grant R01AG092528
Award Date 2/1/26
Completion Date 1/31/31
Dollars Obligated $689K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute on Aging awarded the University of Virginia a $522,167 Project Grant, effective August 1, 2025, through May 31, 2030, under the Aging Research program (CFDA 93.866). The award supports research investigating mechanisms of ribosomal DNA (rDNA) instability during aging, with the objective of understanding how genomic instability contributes to the aging process. The research focuses on characterizing the roles of the FOB1 protein and...
- Federal Grant Award Summary The University of Virginia received a $726,452 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 15, 2025, with a completion date of April 30, 2029. This research award funds the development and application of computational and experimental methods to model intra- and inter-cellular signaling networks mediating Transient Receptor Potential Cation Channel,...
- Federal Grant Award Summary The University of Virginia received a $759,095 Project Grant award from the National Institute on Aging (Aging Research program, CFDA 93.866) on May 15, 2025, with completion targeted for February 28, 2030. The award funds research and development of magnetic resonance (MR) image-guided focused ultrasound (FUS) technology combined with microbubbles to selectively deliver SHIP-1 neutralizing therapies across the blood-brain barrier to brain-resident microglia. The...
- Federal Project Grant Award Summary The University of Missouri System received a $429,394 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded December 15, 2025, with completion targeted for November 30, 2027. This research initiative addresses heart failure with preserved ejection fraction (HFpEF) in aging populations with comorbid conditions such as obesity and hypertension. The project focuses on investigating LARP6 (LA...
- Federal Grant Award Summary The University of Virginia received an $806,901 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, with completion targeted for May 31, 2030. This research grant funds investigation into oxidation-specific epitope immunoglobulin A (IgA) responses in idiopathic pulmonary fibrosis (IPF) pathogenesis. The research program will examine the role of IgA...
- Federal Grant Award Summary The University of Virginia received $802,611 in project grant funding from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 15, 2025, with completion targeted for August 31, 2029. This grant supports the development of improved cardiac magnetic resonance imaging (MRI) methods to quantify epicardial adipose tissue (EAT) composition and demonstrate their clinical application in...
- Federal Project Grant Award Summary The University of Virginia received a $644,997 Project Grant award dated August 21, 2025, from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports research to identify and validate plasma proteomic biomarkers for early and late-stage pulmonary fibrosis, with completion targeted for May 31, 2030. This research addresses a critical gap in idiopathic pulmonary fibrosis (IPF)...
- Federal Grant Award Summary The University of Virginia received a $666,319 Project Grant award dated August 18, 2025, from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The project, titled "Nanotherapeutic Strategies for the Treatment of Chronic Chagas Disease," will be conducted through May 31, 2029, and focuses on developing and validating nanotherapy platforms to address critical treatment challenges...
- Federal Grant Award Summary The University of Virginia received a $732,261 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 15, 2025, through June 30, 2029. The award funds research to identify and validate genetic factors contributing to central obesity through functional analysis of genome-wide association study (GWAS) loci. The project leverages multi-ethnic, multi-omic data...
- Federal Grant Award Summary The National Institute on Aging awarded Duke University a $680,818 Project Grant effective February 1, 2026, through January 31, 2031, under the Aging Research program (CFDA 93.866) to conduct the INFUSE HFPEF (Iron Needed for Function and Undesirable Symptoms in Elderly with Heart Failure with Preserved Ejection Fraction) study. This double-blind, placebo-controlled randomized clinical trial will evaluate the efficacy of intravenous iron supplementation in 300...